BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221117T090000
DTEND;TZID=America/Toronto:20221119T150000
DTSTAMP:20260505T130936
CREATED:20221016T183726Z
LAST-MODIFIED:20221016T183726Z
UID:22029-1668675600-1668870000@scienceinboston.com
SUMMARY:ISSCR Boston International Symposium
DESCRIPTION:Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical\, Manufacturing\, and Regulatory Strategies for Success\n“Experts in the preclinical\, clinical\, and regulatory phases discuss critical processes and strategies in development of PSC-derived therapies: selecting the cell line\, characterizing the product and manufacturing considerations\, managing the immune system\, and working with regulators throughout the process.” \nSpeakers & Topics\nPreclinical Strategies\nSponsored by : Astellas Institute for Regenerative Medicine \nApril Craft\, PhD\, Boston Children’s Hospital\, USA\nDoug Melton\, PhD\, Vertex Pharmaceuticals and Harvard University\, USA\nSu-Chun Zhang\, MD\, PhD\, Duke-NUS Medical University\, Singapore and University of Wisconsin-Madison\, USA\nKareen Coulombe\, PhD\, Brown University\, USA\n \nSelecting Your Cell Line: Derivation and Characterization\nSponsored by: ElevateBio \nTenneille Ludwig\, PhD\, WiCell\, USA\nNissim Benvenisty\, PhD\, Hebrew University\, Israel\nJennifer Dashnau\, PhD\, Century Therapeutics\, USA \nWhat’s In Your Product\nBahram (Bob) Valamehr\, PhD\, MBA\, FATE Therapeutics\, USA\nAngela Keightley\, PhD\, BlueRock Therapeutics\, Canada \nNew Technologies/Where Are We Going?\nHoward Kim\, PhD\, The New York Stem Cell Foundation (NYSCF)\, USA\nKapil Bharti\, PhD\, NIH\, USA\nPeter Zandstra\, PhD\, University of British Columbia\, Canada\nOdette Becheau\, TreeFrog Therapeutics\, France\nKiera Dwyer\, Brown University\, USA \nImmunology for Cell Therapies\nRan Jing\, PhD\, Harvard Medical School\, USA\nSonja Schrepfer\, MD\, PhD\, Sana Biotechnology\, USA\nShin Kaneko\, MD\, PhD\, CiRA\, Kyoto University\, Japan \nBalancing Science and Regulatory Requirements in Emerging Fields\nSponsored by: Cellino Biotech \nAnthony Oro\, MD\, PhD\, Stanford University\, USA\nGesine Paul-Visse\, MD\, Lund University\, Sweden\nMelissa Carpenter\, PhD\, ElevateBio\, USA \nHow to Accelerate with Accelerated Designations\nJane Lebkowski\, PhD\, Regenerative Patch Technologies\, USA\nMasayo Takahashi\, MD\, Vision Care\, Inc.\, Japan \nDelivering Your Cell Product: Strategies for Success\nSponsored by: Vertex Pharmaceuticals \nTimothy Kamp\, MD\, PhD\, University of Wisconsin\, USA\nCory R. Nicholas\, PhD\, Neurona Therapeutics\, USA
URL:https://scienceinboston.com/event/isscr-boston-international-symposium/
LOCATION:Boston Marriott Cambridge\, 50 Broadway\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221117T090000
DTEND;TZID=America/Toronto:20221119T150000
DTSTAMP:20260505T130936
CREATED:20221016T183726Z
LAST-MODIFIED:20221016T183726Z
UID:27877-1668675600-1668870000@scienceinboston.com
SUMMARY:ISSCR Boston International Symposium
DESCRIPTION:Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical\, Manufacturing\, and Regulatory Strategies for Success\n“Experts in the preclinical\, clinical\, and regulatory phases discuss critical processes and strategies in development of PSC-derived therapies: selecting the cell line\, characterizing the product and manufacturing considerations\, managing the immune system\, and working with regulators throughout the process.” \nSpeakers & Topics\nPreclinical Strategies\nSponsored by : Astellas Institute for Regenerative Medicine \nApril Craft\, PhD\, Boston Children’s Hospital\, USA\nDoug Melton\, PhD\, Vertex Pharmaceuticals and Harvard University\, USA\nSu-Chun Zhang\, MD\, PhD\, Duke-NUS Medical University\, Singapore and University of Wisconsin-Madison\, USA\nKareen Coulombe\, PhD\, Brown University\, USA\n \nSelecting Your Cell Line: Derivation and Characterization\nSponsored by: ElevateBio \nTenneille Ludwig\, PhD\, WiCell\, USA\nNissim Benvenisty\, PhD\, Hebrew University\, Israel\nJennifer Dashnau\, PhD\, Century Therapeutics\, USA \nWhat’s In Your Product\nBahram (Bob) Valamehr\, PhD\, MBA\, FATE Therapeutics\, USA\nAngela Keightley\, PhD\, BlueRock Therapeutics\, Canada \nNew Technologies/Where Are We Going?\nHoward Kim\, PhD\, The New York Stem Cell Foundation (NYSCF)\, USA\nKapil Bharti\, PhD\, NIH\, USA\nPeter Zandstra\, PhD\, University of British Columbia\, Canada\nOdette Becheau\, TreeFrog Therapeutics\, France\nKiera Dwyer\, Brown University\, USA \nImmunology for Cell Therapies\nRan Jing\, PhD\, Harvard Medical School\, USA\nSonja Schrepfer\, MD\, PhD\, Sana Biotechnology\, USA\nShin Kaneko\, MD\, PhD\, CiRA\, Kyoto University\, Japan \nBalancing Science and Regulatory Requirements in Emerging Fields\nSponsored by: Cellino Biotech \nAnthony Oro\, MD\, PhD\, Stanford University\, USA\nGesine Paul-Visse\, MD\, Lund University\, Sweden\nMelissa Carpenter\, PhD\, ElevateBio\, USA \nHow to Accelerate with Accelerated Designations\nJane Lebkowski\, PhD\, Regenerative Patch Technologies\, USA\nMasayo Takahashi\, MD\, Vision Care\, Inc.\, Japan \nDelivering Your Cell Product: Strategies for Success\nSponsored by: Vertex Pharmaceuticals \nTimothy Kamp\, MD\, PhD\, University of Wisconsin\, USA\nCory R. Nicholas\, PhD\, Neurona Therapeutics\, USA
URL:https://scienceinboston.com/event/isscr-boston-international-symposium-2/
LOCATION:Boston Marriott Cambridge\, 50 Broadway\, Cambridge\, MA\, 02142\, United States
END:VEVENT
END:VCALENDAR